KT
Kiran Tamrakar
About Kiran Tamrakar
Data last updated:
Kiran Tamrakar is a Director at Nova Pet Private Limited (since 2012) and Director at Nova Zing Pharma Private Limited (since 2005). The companies operate in Manufacturing and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹19.88 Cr; the largest is Nova Pet Private Limited at ₹12.27 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nova Pet Private Limited U25200MP1980PTC001656 | Director | 06 Apr 2012 | 1980 | ₹12.27 Cr (FY 2025) | Active |
| Nova Zing Pharma Private Limited U70101MP1995PTC010112 | Director | 25 May 2005 | 1995 | ₹7.61 Cr (FY 2025) | Active |
Board colleagues of Kiran Tamrakar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nitin Tamrakar | 01049681 | Nova Pet Private Limited , Nova Zing Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kiran Tamrakar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kiran Tamrakar
Kiran Tamrakar currently holds 2 directorships: Nova Pet Private Limited (Director, since 06 Apr 2012, revenue ₹12.27 Cr (FY 2025)); Nova Zing Pharma Private Limited (Director, since 25 May 2005, revenue ₹7.61 Cr (FY 2025)).
Kiran Tamrakar was first appointed on 25 May 2005 as Director at Nova Zing Pharma Private Limited. The most recent appointment on record is 06 Apr 2012 at Nova Pet Private Limited.
The 2 current companies of Kiran Tamrakar that report revenue have a combined latest revenue of ₹19.88 Cr: Nova Pet Private Limited ₹12.27 Cr (FY 2025); Nova Zing Pharma Private Limited ₹7.61 Cr (FY 2025).
The current boards of Kiran Tamrakar's companies include Nitin Tamrakar (Nova Pet Private Limited).